IL6 and colitis: Notably, NINJ1 deficiency enhances lung cancer cell motility by upregulating ICAM-1 through the IL-6/STAT3 signaling pathway [17], while its overexpression suppresses colitis-mediated colon cancer growth by inhibiting macrophage migration and invasion via the repression of FAK signaling [18].